Comparison

Guide AOD vs The Perinatal Memo

Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.

Head to head
About

Guide AOD

This medical reference app provides healthcare professionals with practical information on direct oral anticoagulants. It covers indications, dosages, precautions, interactions, and patient management, including useful calculators for risk assessment and renal clearance.

Highlights
  • Direct oral anticoagulant information
  • Dosage and renal adjustment
  • Precautions and contraindications
  • Bleeding management
  • Peri/post-operative management
  • Risk assessment calculators
Features
Read full description

Le Guide d'utilisation des anticoagulants oraux directs a été réalisé par des professionnels de la santé (médecins, pharmacien(ne)s et infirmières) oeuvrant dans des Centres Universitaires de la région de Québec. Il se veut un ouvrage de référence pratique et facile à consulter pour tous les professionnels (généralistes, spécialistes, pharmacien(ne)s et infirmier(ère)s) qui sont impliqués dans le suivi des patients pour lesquels un anticoagulant oral direct (dabigatran (Pradaxa md), rivaroxaban (Xarelto md), apixaban (Eliquis md) ou edoxaban (Lixiana md)) a été prescrit. Le guide fourni de l'information sur les indications et les critères de remboursements, les posologies (dont l'ajustement en insuffisance rénale), les précautions et contre-indications, les paramètres pharmacocinétiques, les interactions, la gestion péri et post-opératoire, la gestion des saignements, ainsi que les recommandations sur le suivi des patients. Des calculatrices utiles pour le calcul de la clairance à la créatinine ainsi que pour les échelles de risque CHADS₂, CHA₂DS₂VASC et HAS-BLED ont été intégrées afin de faciliter la prise en charge du patient. L'utilisateur doit toutefois prendre en considération que le guide a d'abord été créé par et pour les professionnels de la santé des Centres Universitaires de la région de Québec avec les particularités propres à leurs milieux spécialisés. L'utilisation du guide doit faire l'objet d'adaptations en fonction du milieu et du jugement clinique. L'application du Guide d’utilisation des AODs est une réalisation de Effenti inc. (www.effenti.ca)

About

The Perinatal Memo

A quick reference guide for healthcare professionals on Canadian perinatal care recommendations and practice guidelines. It covers evidence-based information for pregnant women, childbirth, and newborns.

Highlights
  • Canadian perinatal care guidelines
  • Evidence-based recommendations
  • Covers pregnancy, childbirth, and newborns
  • Quick reference for professionals
  • Designed for family physicians, midwives, nurses
Features
Read full description

Written by practicing family physicians and educators, this quick reference book is intended for family doctors involved in prenatal care or deliveries, as well as midwives, nurses, and other professionals in the field of perinatal care. It is also useful for students and trainees in these disciplines. This application aims to provide a summary of the main evidence-based Canadian recommendations and practice guidelines in the field of perinatal care, including care for pregnant women, childbirth, and newborns. Disclaimer: This document is intended for healthcare professionals and is not designed to provide information to the general population regarding perinatal care. If you are pregnant and experiencing a problem or complication, please consult your healthcare professional. Privacy Policy: https://memoperinatalite.ca/privacy.html Terms of Use: https://www.apple.com/legal/internet-services/itunes/dev/stdeula/

Screenshots

Guide AOD2 screens
The Perinatal Memo4 screens

Verdict

The call

The clearest difference is review sentiment: The Perinatal Memo at 100% against Guide AOD's 33%. The Perinatal Memo also leads on iOS requirement (15.1 vs 18.6). Guide AOD's advantage is price (Free vs $39.99) and in-app purchases (none vs 1). On update cadence, ads and device support there is nothing between them.

Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS

CostPrice · In-app purchases · Ads · Monetization

Guide AOD is free to download; The Perinatal Memo costs $39.99 up front. The Perinatal Memo sells 1 in-app purchase, starting at $19.99 per year. Guide AOD asks for nothing beyond the download.

UpkeepUpdate frequency

Both ship on a similar rhythm, roughly every 2 months. The most recent releases landed on October 16, 2026 and October 9, 2026 respectively.

Scorecard5 real differences · 3 level
Guide AOD versus The Perinatal Memo: the parameters behind the verdict, then further details
ParameterGuide AODThe Perinatal Memo
PriceFree — better$39.99
Positive reviews33.3% of reviews100.0% of reviews — better
Update frequencyEvery 2 monthsEvery 2 months
AdsNoNo
In-app purchasesNo — betterYes
MonetizationFree — betterPaid
DevicesiPhoneiPhone, iPod — better
Requires iOS18.615.1 — better
Further details — not scored
Size3 MB112 MB
Age rating17+17+
DeveloperL'Institut universitaire de cardiologie et de pneumologie de Québec (IUCPQ)Les Editions Memos S.E.N.C.

Customer experience

Guide AOD

Written reviews3 reviews
Positive33.3%
Neutral33.3%
Negative33.3%

The Perinatal Memo

Written reviews5 reviews
Positive100.0%
Neutral0.0%
Negative0.0%

In-app purchases

None

Guide AOD

No in-app purchases

1 purchases

The Perinatal Memo

Subscriptions1
  • Abonnement au contenu1 Year trial$19.991 Year

Questions

Is Guide AOD free?
Guide AOD is free to download, with no in-app purchases.
Is The Perinatal Memo free?
The Perinatal Memo costs $39.99, and also offers in-app purchases.
Do Guide AOD or The Perinatal Memo have ads?
Neither Guide AOD nor The Perinatal Memo shows ads.
Which is updated more often, Guide AOD or The Perinatal Memo?
Guide AOD ships an update every 2 months, and The Perinatal Memo every 2 months. Most recently, Guide AOD was updated on October 16, 2026 and The Perinatal Memo on October 9, 2026.

Other comparisons